Cargando…

DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease

Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in cell models...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Bhagyashree S., Youssef, Sameh A., Bron, Reinier, de Bruin, Alain, Kampinga, Harm H., Zuhorn, Inge S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564107/ https://www.ncbi.nlm.nih.gov/pubmed/34755099 http://dx.doi.org/10.1016/j.isci.2021.103282

Ejemplares similares

Preparation of chaperone-loaded neural stem cell-derived extracellular vesicles to reduce protein aggregation in Huntington’s disease cellular models
por: Joshi, Bhagyashree S., et al.
Publicado: (2023)

DNAJB6-Containing Extracellular Vesicles as Chaperone Delivery Systems: A Proteomic Analysis
por: Joshi, Bhagyashree S., et al.
Publicado: (2022)

Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation
por: Rodríguez-González, Claudio, et al.
Publicado: (2020)

DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios
por: Månsson, Cecilia, et al.
Publicado: (2013)

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
por: Kuiper, E. F. E., et al.
Publicado: (2017)

Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes
por: Joshi, Bhagyashree S., et al.
Publicado: (2020)

Heparan sulfate proteoglycan‐mediated dynamin‐dependent transport of neural stem cell exosomes in an in vitro blood–brain barrier model
por: Joshi, Bhagyashree S., et al.
Publicado: (2020)

Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012)

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation
por: Furtado, Gabriel Vasata, et al.
Publicado: (2021)

Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington’s disease model system
por: Xi, Wen, et al.
Publicado: (2016)

The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells
por: Deshayes, Natasja, et al.
Publicado: (2019)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells
por: Aliyandi, Aldy, et al.
Publicado: (2021)

Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
por: Sugaya, Keizo, et al.
Publicado: (2007)

Nanogels with Selective Intracellular Reactivity for Intracellular Tracking and Delivery
por: Zu, Guangyue, et al.
Publicado: (2020)

CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
Publicado: (2019)

Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
por: Daldin, Manuel, et al.
Publicado: (2017)

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005)

Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity
por: Leach, Michelle D., et al.
Publicado: (2016)

Formation and persistence of polyglutamine aggregates in mistranslating cells
por: Lant, Jeremy T, et al.
Publicado: (2021)

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
por: Rose, Claudia, et al.
Publicado: (2010)

Monomeric, Oligomeric and Polymeric Proteins in Huntington Disease and Other Diseases of Polyglutamine Expansion
por: Hoffner, Guylaine, et al.
Publicado: (2014)

Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington’s disease
por: Matlahov, Irina, et al.
Publicado: (2019)

Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington’s Disease
por: Pradhan, Subrata, et al.
Publicado: (2022)

Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
por: Howard, Rebecca A, et al.
Publicado: (2007)

Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation
por: Perez, Matthew K., et al.
Publicado: (1998)

Cell-to-cell Transmission of Polyglutamine Aggregates in C. elegans
por: Kim, Dong-Kyu, et al.
Publicado: (2017)

Molecular dynamics analysis of the aggregation propensity of polyglutamine segments
por: Wen, Jingran, et al.
Publicado: (2017)

Nuclear polyglutamine-containing protein aggregates as active proteolytic centers
por: Chen, Min, et al.
Publicado: (2008)

Prion Formation and Polyglutamine Aggregation Are Controlled by Two Classes of Genes
por: Manogaran, Anita L., et al.
Publicado: (2011)

Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates
por: Wear, Maggie P., et al.
Publicado: (2015)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation
por: Teuling, Eva, et al.
Publicado: (2011)

The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
por: Aprile, Francesco A., et al.
Publicado: (2017)

Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington’s Disease Monkeys
por: Clever, Faye, et al.
Publicado: (2019)

Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
por: Suhr, Steven T., et al.
Publicado: (2001)

An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation
por: Oppong, Emmanuel, et al.
Publicado: (2017)

A homogeneous dataset of polyglutamine and glutamine rich aggregating peptides simulations
por: Barrera, Exequiel E., et al.
Publicado: (2021)

Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal
por: Kandola, Tej, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_frs4raahjsfmalm7mhq23ftsuk